Literature DB >> 14711729

Normative data for a user-friendly paradigm for pattern electroretinogram recording.

Vittorio Porciatti1, Lori M Ventura.   

Abstract

PURPOSE: To provide normative data for a user-friendly paradigm for the pattern electroretinogram (PERG) optimized for glaucoma screening (PERGLA).
DESIGN: Prospective nonrandomized case series. PARTICIPANTS: Ninety-three normal subjects ranging in age between 22 and 85 years.
METHODS: A circular black-white grating of 25 degrees visual angle, reversing 16.28 times per second, was presented on a television monitor placed inside a Ganzfeld bowl. The PERG was recorded simultaneously from both eyes with undilated pupils by means of skin cup electrodes taped over the lower eyelids. Reference electrodes were taped on the ipsilateral temples. Electrophysiologic signals were conventionally amplified, filtered, and digitized. Six hundred artifact-free repetitions were averaged. The response component at the reversal frequency was isolated automatically by digital Fourier transforms and was expressed as a deviation from the age-corrected average. The procedure took approximately 4 minutes. MAIN OUTCOME MEASURES: Pattern electroretinogram amplitude ( micro V) and phase (pi rad); response variability (coefficient of variation [CV] = standard deviation [SD] / mean x 100) of amplitude and phase of 2 partial averages that build up the PERG waveform; amplitude ( micro V) of background noise waveform, obtained by multiplying alternate sweeps by +1 and -1; and interocular asymmetry (CV of amplitude and phase of the PERG of the 2 eyes).
RESULTS: On average, the PERG has a signal-to-noise ratio of more than 13:1. The CVs of intrasession and intersession variabilities in amplitude and phase are lower than 10% and 2%, respectively, and do not depend on the operator. The CV of interocular asymmetries in amplitude and phase are 9.8+/-8.8% and 1.5+/-1.4%, respectively. The PERG amplitude and phase decrease with age. Residuals of linear regression lines have normal distribution, with an SD of 0.1 log units for amplitude and 0.019 log units for phase. Age-corrected confidence limits (P<0.05) are defined as +/-2 SD of residuals.
CONCLUSIONS: The PERGLA paradigm yields responses as reliable as the best previously reported using standard protocols. The ease of execution and interpretation of results of PERGLA indicate a potential value for objective screening and follow-up of glaucoma.

Entities:  

Mesh:

Year:  2004        PMID: 14711729      PMCID: PMC2760457          DOI: 10.1016/j.ophtha.2003.04.007

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  51 in total

1.  Standard for pattern electroretinography. International Society for Clinical Electrophysiology of Vision.

Authors:  M Bach; M Hawlina; G E Holder; M F Marmor; T Meigen; Y Miyake
Journal:  Doc Ophthalmol       Date:  2000-07       Impact factor: 2.379

2.  Comparison of psychophysical and electrophysiological testing in early glaucoma.

Authors:  S L Graham; S M Drance; B C Chauhan; N V Swindale; P Hnik; F S Mikelberg; G R Douglas
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-12       Impact factor: 4.799

3.  Transiently raised intraocular pressure reveals pattern electroretinogram losses in ocular hypertension.

Authors:  A Colotto; B Falsini; T Salgarello; L Buzzonetti; S Cermola; G Porrello
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-12       Impact factor: 4.799

4.  The pattern electroretinogram and visual-evoked potential in glaucoma.

Authors:  M J Price; S M Drance; M Price; M Schulzer; G R Douglas; B Tansley
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

5.  Variability of the pattern electroretinogram.

Authors:  K Holopigian; J Snow; W Seiple; I Siegel
Journal:  Doc Ophthalmol       Date:  1988-09       Impact factor: 2.379

6.  Human pattern-evoked electroretinogram.

Authors:  R F Hess; C L Baker
Journal:  J Neurophysiol       Date:  1984-05       Impact factor: 2.714

7.  Recording the pattern electroretinogram: a cautionary note.

Authors:  W H Seiple; I M Siegel
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-06       Impact factor: 4.799

8.  Detection of optic neuropathy in glaucomatous eyes with normal standard visual fields using a test battery of short-wavelength automated perimetry and pattern electroretinography.

Authors:  Andreas U Bayer; Klaus-Peter Maag; Carl Erb
Journal:  Ophthalmology       Date:  2002-07       Impact factor: 12.079

9.  A 3-year follow-up study of ocular hypertension by pattern electroretinogram.

Authors:  M Arai; N Yoshimura; H Sakaue; E Chihara; Y Honda
Journal:  Ophthalmologica       Date:  1993       Impact factor: 3.250

10.  ERG electrode in pediatric patients: comparison of DTL fiber, PVA-gel, and non-corneal skin electrodes.

Authors:  S G Coupland; M Janaky
Journal:  Doc Ophthalmol       Date:  1989-04       Impact factor: 2.379

View more
  66 in total

1.  Pattern electroretinogram progression in glaucoma suspects.

Authors:  Lori M Ventura; Iuri Golubev; William J Feuer; Vittorio Porciatti
Journal:  J Glaucoma       Date:  2013-03       Impact factor: 2.503

2.  Progressive loss of retinal ganglion cell function is hindered with IOP-lowering treatment in early glaucoma.

Authors:  Lori M Ventura; William J Feuer; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

3.  Head-down posture induces PERG alterations in early glaucoma.

Authors:  Lori M Ventura; Iuri Golubev; William Lee; Izuru Nose; Jean-Marie Parel; William J Feuer; Vittorio Porciatti
Journal:  J Glaucoma       Date:  2013-03       Impact factor: 2.503

4.  Pattern electroretinogram association with spectral domain-OCT structural measurements in glaucoma.

Authors:  C Bowd; A Tafreshi; L M Zangwill; F A Medeiros; P A Sample; R N Weinreb
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

5.  Pattern electroretinogram and psychophysical tests of visual function for discriminating between healthy and glaucoma eyes.

Authors:  Ali Tafreshi; Lyne Racette; Robert N Weinreb; Pamela A Sample; Linda M Zangwill; Felipe A Medeiros; Christopher Bowd
Journal:  Am J Ophthalmol       Date:  2010-03       Impact factor: 5.258

6.  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

Authors:  Vincenzo Parisi
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

7.  Habituation of retinal ganglion cell activity in response to steady state pattern visual stimuli in normal subjects.

Authors:  Vittorio Porciatti; Nancy Sorokac; William Buchser
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

8.  Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial.

Authors:  Byron L Lam; William J Feuer; Joyce C Schiffman; Vittorio Porciatti; Ruth Vandenbroucke; Potyra R Rosa; Giovanni Gregori; John Guy
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

9.  Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram.

Authors:  Benedetto Falsini; Dario Marangoni; Tommaso Salgarello; Giovanna Stifano; Lucrezia Montrone; Salvatore Di Landro; Laura Guccione; Emilio Balestrazzi; Alberto Colotto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-17       Impact factor: 3.117

10.  Adaptation of the steady-state PERG in early glaucoma.

Authors:  Vittorio Porciatti; Brandon Bosse; Prashant K Parekh; Olga A Shif; William J Feuer; Lori M Ventura
Journal:  J Glaucoma       Date:  2014 Oct-Nov       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.